Several studies indicate that interleukin-1 receptor antagonist (IL-1ra) is an important regulator of host immunity and play a key role in cancers development. Some of these studies have shown a potential role of a variable number of tandem repeat (VNTR) of 86 bp polymorphism within IL-1ra gene (IL-1RN) in host immune response variability. We investigated what VNTR polymorphism involves in susceptibility to ovarian cancer in Tunisia with a case control study.
Introduction
Ovarian cancer occupies the third rank among cancer in women in Tunisia and its incidence is about 4,1 cases/100000 women [Ben Abdallah, 2012] . The majority of patients diagnosed with ovarian cancer present advanced-stage disease, indeed it is mostly symptomless in early stages and there are currently no effective screening methods. Although, hormonal factors, inflammation, and wound healing are thought to play important roles in its occurrence, the etiology of ovarian cancer remains unknown [Risch, 1998] . Many genetic association studies have been already performed in cancer and suggested that tumor predisposition may be due to the combination of low penetrance genetic variants [Balmain, 2003; Kotnis, 2005] including genes coding for proinflammatory cytokines and their receptors [Balkwill, 2001; Martin Howell, 2007] . Interleukin-1 (IL-1), an inflammatory regulator, plays an important role in the development of several pathologies [Alrayes, 2003; Langdahl, 2000] . The IL-1 gene family is located on chromosome 2q and includes IL-1A, IL-1B, and IL-1RN genes, which encode IL-1α, IL-1 β, and IL-1 receptor antagonist (IL-1ra) [Hefler, 2002] . This receptor is in anti-inflammatory cytokine which acts as competitive inhibitor to control the inflammatory action of IL-1 by binding to the IL-1 receptor [Arend, 1998] . Within the IL-1RN gene, a variable number of tandem repeats (VNTR) of 86-bp length was found to correlate with many diseases [Alrayes, 2003; Langdahl, 2000; Al-Moundhri, 2006; Sehouli, 2002] . Nevertheless, there are limited reports on the influence of this variant with host susceptibility to ovarian cancer and the results are controversial [Sehouli, 2003; Hefler, 2002] .
In the present study, we investigated the association between the IL-1RN VNTR polymorphism and susceptibility to ovarian cancer and its correlation with established clinical prognostic factors in Tunisian patients in North Africa (figure1). 
Materials and Methods

Sample Collection
All blood samples were collected from histopathological confirmed Tunisian patients with ovarian cancer (n=55) and unrelated, healthy female controls of similar ethnicity (n=257). Clinical diagnosis/staging of ovarian cancer patients was performed by trained medical personnel as per the guidelines outlined by the International Federation of Gynecology and Obstetrics (FIGO). Written informed consent was taken from all subjects and the study was approved by local ethics committees of the Salah Azeiz Institute of oncology.
Blood Collection and DNA Extraction
Five milliliters of venous blood with EDTA, as an anticoagulant, were collected from each subject. The blood was obtained from patients prior to radiation therapy or chemotherapy.
Genomic DNA was extracted using QIAamp® DNA blood Mini Kit (QiagenGmbH, Hilden).
IL-1RN Gene Polymorphism
The polymorphic region within the second intron of IL-1RN, which contains a VNTR of 86-pb, was amplified by polymerase chain reaction with specific primers: forward, 5' CTCCAGCAACACTCCTAT 3'; reverse, 5' TCCTGGTCTGCAGGTAA 3'. For each sample, the PCR was performed in a total reaction volume of 10µl containing 1µl (100 ng) genomic DNA, 25mM of dNTP, 1µl of buffer 10X and 0,25U of Taq polymerase (Fermentas). The PCR cycling program comprised an initial denaturation at 95 •C for 10 minutes, followed by 30 cycles of 95
•C for 20 seconds, annealing of primers at 51 •C for 30 seconds and extension at 72 •C for 50 seconds and a final extension at 72°C for 10 minutes. Amplified DNA fragments were separated on 1.5% ethidium bromide agarose gel, and visualized under ultraviolet light.
Statistical Analysis
Allele and genotype frequencies were calculated by direct counting and compared with the χ2 or Fisher's exact test when appropriate (e.g., the number of subjects in a cell was less than 5) using the EPI The distribution of pooled genotypes between carriers and non carriers of allele 1 shows a p value<0,005 however the confidence interval at 95% for odds ratio includes 1, so this association is not statistically significant (table 3) . [Dinarello, 1996; Fujiwaki, 1997; Viet, 2005] . The role of this cytokine as a mediator of malignant tumour growth has been reported for cervical [Fujiwaki, 1997; Zeisler, 1998 ], ovarian [Li, 1992] , gastric [El Omar, 2001] , and colorectal carcinogenesis [Viet, 2005] .
Several studies have investigated the role of a common IL-1 RN VNTR polymorphism in the development of inflammatory disorders [Viet, 2005; Fujiwaki, 2003 ]. The majority of these studies have been enrolled on cancers, such as gastric [AlMoundhri, 2006; Geon Shin, 2008] , bladder [Bid, 2006] , breast [Lee, 2007] , colorectal [Viet, 2005] , cervical [Sousa, 2012; Fujiwaki, 2003 ], vulvar [Grimm, 2004] , and ovarian [Sehouli, 2003; Hefler, 2002] . Nevertheless, there are controversial results regarding the potential role of this polymorphism in the development of cancer. In the present study, we attempted to establish an association between the IL-1RN VNTR polymorphism and susceptibility to ovarian cancer and its In our study, carriers of allele 1 have an almost twofold increased risk of developing ovarian cancer specifically it's associated to Serous-papillary type susceptibility. This allele seems to be the critical point in the molecular pathway of some diseases. In fact, it has recently been correlated with a higher risk of Multidrug-resistant Acinetobacter baumannii associated pneumonia [Hsu, 2012] . In literature, the presence of allele 1 is associated in general with a restricted immune reaction and the level of IL-1ra production in human endothelial cells with genotype 1/1 is three times higher than with 2/2 genotypes. However, the presence of allele 2 is correlated with a prolonged immune reaction [Dewberry, 2000] . The other alleles are rarely detected and positive or negative effect in inflammatory reaction is not elsewhere described [Witkin, 2002] . Contrary to our results, however, Hefler et al. [2002] have published a case-control study where IL1-RN VNTR polymorphism was genotyped in 94 ovarian cancer patients and 134 healthy women in the Austrian population and found no differences in the prevalence of the VNTR polymorphism in the IL-1RN between cases and controls. However, in Germany, Sehouli et al. [2003] have analysed this polymorphism in 108 women with ovarian cancer compared to 112 patients with benign gynaecological diseases and obtain results suggesting that the allele 2 seems to play a role in the occurrence of ovarian cancer.
Otherwise, our results have revealed, for the first time, a negative association between allele 3 and the occurrence of ovarian cancer in Tunisian women. This allele is rarely detected and his biological meaning on immune reaction is not elsewhere elucidated [Witkin, 2002] . Therefore, the VNTR polymorphism in the IL-1RN should be analyzed in further casecontrol studies in order to better evaluate this marker as a risk factor for ovarian cancer. Otherwise it needs to be pointed out that there were some limitations in this study. First, the limited sample size may restrict us to identify other genotype or allele associations. Second, our study lacked the measurement of IL-1ra and IL-1β levels in the local environment of ovarian cancer and the representative of circulating IL-1ra and IL-1β levels need to be investigated in further studies. Furthermore, power analysis showed that to achieve a power of 80% at an alpha of 0, 05 another 81729 patients would have to be genotyped, in light of the observed allelic frequencies.
In addition, we didn't observe any association between specific alleles and clinical features such as FIGO stage and histological types. Similar results were obtained by Hefler et al. [2002] and Sehouli et al. [2003] . It can thus speculate that IL-1 RN VNTR polymorphism doesn't influence ovarian cancer biology.
In conclusion, we observed a significant association of the allele 1 with Serouspapillary type and in the susceptibility to ovarian cancer in Tunisian women. However, the allele 3 is a protective factor for this pathology in Tunisia.
